Navigation Links
Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18

BALTIMORE, March 17 /PRNewswire-USNewswire/ -- The following was issued today by the Greater Baltimore Committee:


Donald C. Fry, president & CEO, Greater Baltimore Committee

140 company owners, executives and researchers from the Baltimore-area bioscience community


The third annual Greater Baltimore Region Bioscience Awards


Tuesday, March 18, 2008

8:00 a.m. / Breakfast & Registration

8:45 - 9:30 a.m. / Awards Program


Renaissance Harborplace Hotel, 202 East Pratt Street, Baltimore, MD 21202


More than 140 leaders from the Baltimore region's bioscience industry and research community will attend a breakfast reception at the Greater Baltimore Committee to honor winners of the 2008 Greater Baltimore Region Bioscience Awards.

This is the third annual awards event presented by the Greater Baltimore Committee, the region's most prominent organization of business and civic leaders, to recognize outstanding achievements in the region's bioscience industry. The Greater Baltimore Committee has made support for the emerging bioscience industry in the region one of its top long-term priorities.

Award winners, to be announced, were selected from among 22 nominations submitted by businesses, bioscience advocates, higher education institutions and government officials.

Awards will be presented in the following categories: Best New Product or Progress Award, Entrepreneurship Award, Leadership in Bioscience Award, and President's Award.

Nominees for this year's awards are:

Best New Product or Progress Award

-- Kris Appel, President & CEO, Encore Path, Inc.

-- Timothy E. Askew, President & CEO, CSA Medical, Inc.

-- James Campbell, M.D., CEO, Arcion Therapeutics

-- William G. Hearl, Ph.D., Founder & President, Immunomic Therapeutics, Inc.

-- Ryan Sysko, Founder & CEO, WellDoc Communications, Inc.

Entrepreneurship Award

-- Mohamed S. Al-Ibrahim, MB ChB, FACP, COO & President, SNBL Clinical Pharmacology Center, Inc.

-- Scott Allocco, President, BioMarker Strategies, LLC

-- Atul Bedi, M.D., Founder, President & Chief Executive Officer, IATRICa Inc.

-- David S. Block, Founder & CEO, Gliknik, Inc.

-- Julie D. Suman, R.Ph., Ph.D., Co-founder & President, Next Breath, LLC

-- Reza Mazhari, Ph.D., VP, Research & Pharmacology and Peter Suzdak, Ph.D.,President/CEO & Co-founder, Cardioxyl Pharmaceuticals, Inc.

-- Jian Wang, Ph.D., President & CEO, BioFortis

Leadership in Bioscience Award

-- Drew M. Pardoll, M.D., Ph.D., Amplimmune

-- Blake M. Paterson, M.D., CEO and Co-founder, Alba Therapeutics Corporation

President's Award

-- Stephen P. Auvil, Co-PI, Director, Office of Technology Development, UMBC and the ACTiVATE Program

-- Delegate Dan K. Morhaim, M.D., The Maryland House of Delegates, 11th District, Baltimore County

-- David J. Ramsay, DM, DPhil, President, University of Maryland, Baltimore

-- John T. (Jack) Shannon, Jr., President and CEO, East Baltimore Development Inc. and Scott Levitan, Senior Vice President, Development Director, Forest City Science + Technology Group, Forest City - New East Baltimore Partnership

-- Paul Silber, Former President/CEO & Founder, InVitro Technologies, Inc.

-- Kathleen O'Donnell Weiss, Executive Director, The BioTechnical Institute of Maryland, Inc.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.

To attend and cover this event, contact: Diane Hughes, 410-727-2820, x32

SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
2. University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
3. New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
4. GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
5. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
6. California Stem Cell Board Member Violates Conflict Rules; Should Resign From Committee, Consumer Group Says
7. Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings
8. California IVF Experts Tap Ethics Committee for Guidance
9. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
10. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
11. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
Breaking Biology Technology:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
Breaking Biology News(10 mins):